CITICOLINE SODIUM is a novel nutrient with a broad spectrum of benefits for conditions associated with symptoms of neurological dysfunction shows promise of clinical efficacy in elderly patients with cognitive deficits, inefficient memory, and early-stage Alzheimer's disease.

Dexmedetomidine Hydrochloride (HCl) stands as a pivotal chemical for the pharmaceutical sector, utilized primarily as a sedative, anxiolytic, and analgesic agent. Under the umbrella of performance materials, this product maintains a strong presence within medical settings, with a focus on providing sedation for non-intubated patients before and/or during surgical and other procedures. It's also used in intensive care sedation for intubated, mechanically ventilated patients. Manufactured in adherence to stringent standards, Dexmedetomidine HCl is a white or almost white powder that dissolves freely in DMSO and is slightly soluble in methanol and water, ensuring its ease of adoption in various pharmaceutical formulations. Our product complies with the United States Drug Master File (US DMF), and proudly carries the European Union Good Manufacturing Practice (EU GMP) certification, attesting to its high-grade quality and the thoroughness of its production process. Beyond its uses, this product is defined by its anatomical therapeutic chemical classification, which refers to a system used for the classification of drugs. A prime focus is on organic purity, with individual impurities like Dimethylphenylethyl imidazole and Levomedetomidine meticulously controlled to exceed pharmacopeial standards. Our product boasts a laudable enantiomeric purity and an assay value ranging between 98.0% and 102.0%, exemplifying its consistency and reliability. It is vital to note that our Dexmedetomidine HCl maintains permissible thresholds for residual solvents, ensuring the safety and efficacy of the drug. The list of related substances and required specifications for solvents like acetone, ethanol, and benzene are rigorously quantified below recognized safety limits, aligning with the highest regulatory expectations. We ensure that each batch is synonymous with excellence, a testament to our unwavering commitment to the highest quality standards in pharmaceutical ingredients. By choosing our Dexmedetomidine HCl, stakeholders in the pharmaceutical industry can confidently incorporate a product that is not only potent and versatile but also conforms to the critical parameters of drug safety and manufacturing excellence. For more information, please visit our website or contact our customer service team, who stand ready to assist with product inquiries and logistic details.

Products still subject to third-party patent protection might be available solely for R&D purposes.

Deferasirox, marketed under the brand Refarmed Chemicals, is a cornerstone in the treatment of chronic iron overload due to blood transfusions in conditions such as thalassemia and sickle cell disease. This condition, if not properly managed, can have severe consequences for organ function. Deferasirox is available in oral tablet form, with strengths of 250 mg, 500 mg, and 1000 mg, allowing for flexibility and precision in dosing to meet individual patient needs. Crafted as an iron chelator, Deferasirox plays a crucial role in binding excess iron within the body and facilitating its excretion through urine. This targeted mechanism asserts its importance in maintaining a healthy balance of iron and preventing the potential toxicity associated with overload. Patients are advised to take Deferasirox with or without food, adhering to a dosing schedule that is tailored to their specific iron levels and bodily response, underscoring the need for a personalized approach to treatment. Regarding its physical properties, Deferasirox appears as a white to pale yellowish crystalline powder, primarily soluble in DMF (Dimethylformamide) and slightly soluble in methanol. These characteristics are essential for ensuring its effectiveness and stability as a pharmaceutical agent. It is imperative that patients undergo regular blood tests and health monitoring for optimum results and to prevent adverse effects such as gastrointestinal distress, skin reactions, and potential liver or renal impairment. Additionally, care must be taken in cases of known hypersensitivity to Deferasirox or pre-existing severe renal or liver conditions. Our documentation and certifications like Good Manufacturing Practice (GMP) and the Drug Master File (DMF) guarantee the highest levels of quality and compliance with industry standards. It is our priority to ensure that this crucial pharmaceutical material is of the utmost purity and efficacy, as reflected in our stringent quality control parameters including the presence of residual solvents and related substances, all documented for your assurance. Please note that while Deferasirox is a vital medication for many patients, it requires diligent medical supervision. Always consult healthcare professionals for specific medical advice and treatment instructions tailored to individual health profiles.

Products still subject to third-party patent protection might be available solely for R&D purposes.

Nadifloxacin: Advanced Antibacterial Solution Refarmed Chemicals presents Nadifloxacin, an efficacious fluoroquinolone antibiotic designed for the assured treatment of various bacterial infections. With its potent broad-spectrum activity, Nadifloxacin offers healthcare professionals a robust option for combating Gram-negative and Gram-positive bacteria, that are often responsible for conditions such as urinary tract infections (UTIs), skin and soft tissue infections, respiratory tract infections, and certain sexually transmitted infections (STIs). Nadifloxacin's pharmacological profile indicates it is generally administered orally via tablets or suspension, with dosing regimens from 500-1000 mg every 12 hours, though this may adjust based on infection severity and individual patient requirements. This medication underscores its commitment to quality and safety, presenting a product that is white to yellowish in crystalline powder form, ensuring high purity with an assay value of ≥ 99.0%. Made with stringent adherence to Good Manufacturing Practice (GMP) standards, Nadifloxacin is both soluble and stable in various solvents, including sodium hydroxide TS and N,N-dimethylformamide (DMF), offering versatile formulation options. Its melting point ranges from 246-250°C, emphasizing its stability under a broad spectrum of conditions. Clarity and color of the solution are maintained as clear, colorless to slight yellow, with stringent checks on impurities – including heavy metals and arsenics kept to minimum levels, aligning with industry standards. While side effects can include nausea, vomiting, diarrhea, and other conditions, they are closely monitored, ensuring optimal patient safety. Patients with hypersensitivity, seizure histories, or on interfering medications are advised to avoid this product and consult healthcare professionals. Nadifloxacin's efficacy is matched only by Refarmed Chemicals' attention to detail and commitment to patient health. With transparent documentation and certification, consumers are assured of the product's integrity, supplemented by the comprehensive information provided by the DKSH Group to facilitate informed decision-making. As a corporate customer looking to source reliable antibiotics, Nadifloxacin represents a high-grade pharmaceutical ingredient that stands for efficacy and safety in the management of bacterial infections.

Products still subject to third-party patent protection might be available solely for R&D purposes.